320 related articles for article (PubMed ID: 22061642)
21. Synthesis and in vitro antitubercular activity of 4-aryl/alkylsulfonylmethylcoumarins as inhibitors of Mycobacterium tuberculosis.
Jeyachandran M; Ramesh P; Sriram D; Senthilkumar P; Yogeeswari P
Bioorg Med Chem Lett; 2012 Jul; 22(14):4807-9. PubMed ID: 22726933
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and screening of galactose-linked nitroimidazoles and triazoles against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Eur J Med Chem; 2011 Sep; 46(9):4725-32. PubMed ID: 21664731
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antituberculosis action of some new pyruvic acid derivatives.
Ungureanu M; Diculencu D; Archip C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):860-4. PubMed ID: 20201282
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
Bioorg Med Chem Lett; 2014 Apr; 24(8):1974-9. PubMed ID: 24679703
[TBL] [Abstract][Full Text] [Related]
25. Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.
Altimari JM; Hockey SC; Boshoff HI; Sajid A; Henderson LC
ChemMedChem; 2015 May; 10(5):787-91. PubMed ID: 25788466
[TBL] [Abstract][Full Text] [Related]
26. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
[TBL] [Abstract][Full Text] [Related]
27. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
[TBL] [Abstract][Full Text] [Related]
30. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones.
Mahajan A; Kremer L; Louw S; Guérardel Y; Chibale K; Biot C
Bioorg Med Chem Lett; 2011 May; 21(10):2866-8. PubMed ID: 21507641
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.
Mugunthan G; Ramakrishna K; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
Bioorg Med Chem Lett; 2011 Jul; 21(13):3947-50. PubMed ID: 21641797
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Soltani F; Rezaee MA; Moshafi MH
Boll Chim Farm; 2003 Nov; 142(9):416-9. PubMed ID: 14971311
[TBL] [Abstract][Full Text] [Related]
37. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems: a novel class of potential antibacterial and antitubercular agents.
Joshi SD; Vagdevi HM; Vaidya VP; Gadaginamath GS
Eur J Med Chem; 2008 Sep; 43(9):1989-96. PubMed ID: 18207286
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
